Recent Finacing
Recent Raise
Cambridge-based R&D biopharmaceutical company developing species-specific monoclonal antibody therapeutics for dogs and cats, translating human antibody discovery platforms into veterinary medicines and advancing programs toward regulatory approval.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
